Europe Bladder Cancer Epidemiology and Patient Flow Analysis, 2017/18-2026

DUBLIN, June 29, 2018 /PRNewswire/ --

The "Europe Bladder Cancer Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The research provides insights into Bladder Cancer epidemiology, Bladder Cancer diagnosed patients, and Bladder Cancer treatment rate for EU5 countries. The research measures key indicators including prevalence of Bladder Cancer derived from epidemiological analysis, patients diagnosed with Bladder Cancer, and patients treated with a drug therapy.

The research study helps executives estimate Bladder Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Bladder Cancer prevalence, Bladder Cancer diagnosis rate, and Bladder Cancer treatment rate for the period 2017-2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Features

• Bladder Cancer Patient Flow
• Bladder Cancer Prevalence
• Bladder Cancer Diagnosed Patients
• Bladder Cancer Treated Patients

Key Topics Covered

1. Bladder Cancer: Disease Definition

2. Bladder Cancer Patient Flow in Europe
2A. Bladder Cancer Prevalence in Europe
2B. Bladder Cancer Diagnosed Patients in Europe
2C. Bladder Cancer Treated Patients in Europe

3. Bladder Cancer Patient Flow in Germany
3A. Bladder Cancer Prevalence in Germany
3B. Bladder Cancer Diagnosed Patients in Germany
3C. Bladder Cancer Treated Patients in Germany

4. Bladder Cancer Patient Flow in France
4A. Bladder Cancer Prevalence in France
4B. Bladder Cancer Diagnosed Patients in France
4C. Bladder Cancer Treated Patients in France

5. Bladder Cancer Patient Flow in Spain
5A. Bladder Cancer Prevalence in Spain
5B. Bladder Cancer Diagnosed Patients in Spain
5C. Bladder Cancer Treated Patients in Spain

6. Bladder Cancer Patient Flow in Italy
6A. Bladder Cancer Prevalence in Italy
6B. Bladder Cancer Diagnosed Patients in Italy
6C. Bladder Cancer Treated Patients in Italy

7. Bladder Cancer Patient Flow in UK
7A. Bladder Cancer Prevalence in UK
7B. Bladder Cancer Diagnosed Patients in UK
7C. Bladder Cancer Treated Patients in UK

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/lhx73c/europe_bladder?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/europe-bladder-cancer-epidemiology-and-patient-flow-analysis-201718-2026-300674794.html

SOURCE Research and Markets